Skip to content

Clinical trials

Bone Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases Country / region: United Kingdom Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20101
20125
20144
20151
20162
20172
20182
20193
20202
20211
20232
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting5
Enrolling by invitation4
Recruiting4
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical9
QED Therapeutics, a BridgeBio company8
Alexion Pharmaceuticals, Inc.5
Amgen3
AstraZeneca1
Bayer1
Great Ormond Street Hospital for Children NHS Foundation Trust1
Iva Hauptmannova1
Novartis Pharmaceuticals1
Relation Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases35
Musculoskeletal Diseases17
Dwarfism15
Achondroplasia13
Osteochondrodysplasias13
Genetic Diseases, Inborn12
Mucopolysaccharidosis IV8
Bone Diseases, Developmental7
Hypophosphatasia5
Osteomalacia5

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.